Yinghui Chen Selected Research

Yinghui Chen Research Topics

Disease

13	Inflammation (Inflammations) 01/2022 - 01/2016
11	Neoplasms (Cancer) 11/2022 - 01/2013
6	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022 - 12/2016
6	Epilepsy (Aura) 01/2019 - 01/2017
6	Drug Resistant Epilepsy 01/2018 - 10/2012
5	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 06/2013
3	Type 2 Diabetes Mellitus (MODY) 01/2020 - 02/2011
3	Demyelinating Diseases (Demyelinating Disease) 01/2019 - 06/2013
3	Glioma (Gliomas) 01/2018 - 05/2015
3	Parkinson Disease (Parkinson's Disease) 01/2016 - 01/2012
2	Pathologic Processes 01/2021 - 01/2017
2	Neuroinflammatory Diseases 01/2020 - 01/2018
2	Nervous System Diseases (Neurological Disorders) 01/2018 - 01/2017
2	Leukemia 07/2017 - 10/2012
2	Carcinoma (Carcinomatosis) 06/2013 - 02/2007
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Fistula 01/2022
1	Muscle Cramp (Cramp) 01/2022
1	Muscular Diseases (Myopathy) 01/2022
1	Pain (Aches) 01/2022
1	Postoperative Pain 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Rhabdomyolysis 01/2022
1	Muscle Weakness 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Hemangioma (Angioma) 11/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Constipation 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Carcinogenesis 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020
1	Lupus Nephritis 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Wounds and Injuries (Trauma) 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2017
1	Hypersensitivity (Allergy) 01/2017

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2017
6	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019 - 10/2012
6	Pharmaceutical PreparationsIBA 01/2018 - 01/2013
5	NAD (NADH)IBA 01/2020 - 06/2013
4	Biological ProductsIBA 11/2021 - 02/2007
4	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2016
3	astaxanthine (astaxanthin)IBA 01/2020 - 01/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 10/2012
3	Pilocarpine (Ocusert)FDA LinkGeneric 01/2019 - 12/2016
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 01/2013
3	CytokinesIBA 01/2017 - 01/2016
2	NF-kappa B (NF-kB)IBA 01/2022 - 01/2022
2	LipopolysaccharidesIBA 01/2022 - 01/2016
2	Long Noncoding RNAIBA 01/2022 - 01/2022
2	AntigensIBA 01/2022 - 01/2018
2	Messenger RNA (mRNA)IBA 11/2021 - 01/2013
2	RNA (Ribonucleic Acid)IBA 01/2021 - 05/2015
2	Circular RNAIBA 01/2021 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 01/2016
2	LithiumIBA 01/2019 - 12/2016
2	Caspase 3 (Caspase-3)IBA 07/2017 - 07/2014
2	thymoquinoneIBA 12/2016 - 01/2016
2	Small Interfering RNA (siRNA)IBA 01/2016 - 01/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 06/2013
2	p38 Mitogen-Activated Protein KinasesIBA 07/2015 - 10/2012
2	LipidsIBA 07/2014 - 02/2011
2	SolutionsIBA 06/2013 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 01/2013 - 02/2007
1	LeptinIBA 01/2022
1	Atorvastatin (Lipitor)FDA Link 01/2022
1	IronIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	OsteopontinIBA 01/2022
1	GlypicansIBA 01/2022
1	Artemether FDA Link 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Niclosamide FDA Link 01/2020
1	Purinergic P2X7 ReceptorsIBA 01/2020
1	Ethanolamine (Colamine)IBA 01/2020
1	SaltsIBA 01/2020
1	Neuroprotective AgentsIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2018
1	raf KinasesIBA 07/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 07/2017
1	Phosphatidylinositols (Phosphatidylinositol)IBA 07/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017
1	AntibodiesIBA 01/2017
1	Ion Channels (Ion Channel)IBA 01/2017
1	ConvulsantsIBA 12/2016
1	Glutamic Acid (Glutamate)FDA Link 01/2016

Therapy/Procedure

4	Therapeutics 01/2020 - 01/2012
2	Microspheres (Microsphere) 06/2013 - 01/2012
2	Drug Therapy (Chemotherapy) 01/2013 - 10/2012
1	Ligation 01/2022
1	Immunotherapy 01/2017